Antiretroviral Information - September 6, 2008

Doctors Hesitant To Prescribe Self-Injectables To HIV Patients

November 18, 2005 - Topics hiv, men, antiretroviral, safety and fuzeon
Initial results from a study, looking at trends with HIV treatment from the viewpoint of the patient and physician, identify some of the mental and physical challenges to self-injectables.

FUZEON presents unique challenges because it is the first self-injectable antiretroviral, whereas all other treatments are oral

read more >>

Mobile Phones Latest Tool In Fight Against HIV/AIDS

November 9, 2005 - Topics hiv, disease, women, child and pregnant
Nine million young people will receive HIV/AIDS awareness text messages.

The U.N. Children's Fund (UNICEF) is launching its Nigerian campaign because it has the third highest number of people with the disease

read more >>

Nigerian Teens To Receive HIV/AIDS Text Messages

November 9, 2005 - Topics hiv, disease, women, child and pregnant
Nine million young people will receive HIV/AIDS awareness text messages.

The U.N. Children's Fund (UNICEF) is launching its Nigerian campaign because it has the third highest number of people with the disease

read more >>

S. African Health Ministry Denies It's Lax On AIDS

September 27, 2005 - Topics aids, africa, hospital, antiretroviral and epidemic
South Africa's health ministry denies accusations that it is not doing enough to fight HIV/AIDS.

Recent comments attack the lack of speed and legislature in place to properly handle the need for HIV/AIDS relief

read more >>

Researchers Putting Hope In Possible HIV Cure

August 14, 2005 - Topics research, hiv, aids, epilepsy and antiretroviral
Although many doctors remain skeptical, there is some rays of hope in the fight of the HIV virus according to details released in the August 13 edition of The Lancet.

Researchers have discovered that the drug valproic acid (Depakote) may be able to reduce the pool of dormant HIV-infected cells in the body

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use